Pfizer obesity drug shows weight loss but side effects cause dropouts

Pfizer's obesity drug PF-3944 shows sustained weight loss but side effects led to 10% trial dropouts, raising concerns as shares fall amid Q4 earnings beat.The post Pfizer obesity drug shows weight loss but side effects cause dropouts first appeared on The Journal Record.